Sources: OpenAI is in talks to raise funding at a $100B+ valuation; Thrive Capital is leading the round, set to invest ~$1B, and Microsoft is expected to invest
Thrive Capital and Microsoft are among investors putting several billion dollars into ChatGPT maker
Context & Ripple Effects
This reported financing discussion follows Microsoft's earlier talks to invest $10 billion at a $29 billion OpenAI valuation, showing how quickly the company’s financing ambitions had scaled.
Later coverage says Thrive contributed more than $1 billion in a $6.5 billion round, while existing backers a16z and Sequoia did not participate, clarifying the changing investor mix around OpenAI.
First-order effects
- If completed as described, the round would give OpenAI several billion dollars of fresh backing at a valuation above $100 billion, with Thrive taking a leading role.
- Microsoft’s expected participation would extend its financial relationship with OpenAI, while Thrive would become a more consequential investor in the company.
Second-order effects
- The round would make investor selection more salient: the later absence of a16z and Sequoia from the $6.5 billion financing indicates that even large OpenAI raises need not accommodate every existing backer.
- A higher valuation and prominent lead investor would reinforce OpenAI’s ability to use private capital to fund its expansion, raising the financing benchmark for other frontier-model developers.
Third-order effects
- The sequence from the earlier $29 billion discussions to this proposed $100 billion-plus valuation, and later funding at a $300 billion valuation, points to a small set of frontier labs becoming unusually dependent on repeated, very large private rounds.
- If this pattern persists, access to capital—and the strategic relationships attached to it—could matter as much as model development in determining which AI labs remain independent competitors.
The trend: Frontier AI is moving toward capital concentration, where a handful of labs rely on ever-larger rounds led by strategic and specialist investors.